A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Levomenthol
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Sparfloxacin.
Levomenthol
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Sparfloxacin.
Levomenthol
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Sparfloxacin.
Levomenthol
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Sparfloxacin.
Levomenthol
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Sparfloxacin.
Levomenthol
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Sparfloxacin.
Levomenthol
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Sparfloxacin.
Levomenthol
Benidipine
The risk or severity of QTc prolongation can be increased when Benidipine is combined with Sparfloxacin.
Levomenthol
Melperone
The risk or severity of QTc prolongation can be increased when Melperone is combined with Sparfloxacin.
Levomenthol
Lenvatinib
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Sparfloxacin.
Levomenthol
Ceritinib
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Sparfloxacin.
Levomenthol
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Sparfloxacin.
Levomenthol
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Sparfloxacin.
Levomenthol
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Sparfloxacin.
Levomenthol
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Sparfloxacin.
Levomenthol
Crizotinib
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Sparfloxacin.
Levomenthol
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Sparfloxacin.
Levomenthol
Nilvadipine
The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Sparfloxacin.
Levomenthol
Panobinostat
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Sparfloxacin.
Levomenthol
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Sparfloxacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3